본문 바로가기

Thromboxane A(2) increases endothelial permeability through upregulation of interleukin-8

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q3
피인용
Web of Science 31
JCR IF
JCR 2009 2.548
ISSN
0006-291X

저자

  1. 김수란제1저자부산대학교, 자연과학대학, 화학과, KO
  2. 배수경부산대학교, 치의학전문대학원, 치의학과, 치의학과, KO
  3. 박현주부산대학교, 부속연구소, 구강생물공학연구소, KO
  4. Kim, MK부산대학교, 치의학전문대학원, 치의학과, KO
  5. 김관회부산대학교, 의과대학, 의과학과, 약리학교실, KO
  6. 박시영부산대학교, 자연과학대학, 분자생물학과, KO
  7. 장혜옥부산대학교, 치의학전문대학원, 치의학과, 치과약리학교실, KO
  8. 윤일희부산대학교, 치의학전문대학원, 치의학과, KO
  9. 김영진부산대학교, 자연과학대학, 분자생물학과, KO
  10. 유미애부산대학교, 자연과학대학, 분자생물학과, KO
  11. 배문경교신저자부산대학교, 치의학전문대학원, 치의학과, 구강생리학교실, KO

초록

Thromboxane A(2) (TXA(2)), a major prostanoid formed from prostaglandin H-2 by thromboxane synthase, is involved in the pathogenesis of a variety of vascular diseases. In this study, we report that TXA(2) mimetic U46619 significantly increases the endothelial permeability both in vitro and in vivo. U46619 enhanced the expression and secretion of interleukin-8 (IL-8), a major inducer of vascular permeability, in endothelial cells. Promoter analysis showed that the 1346619-induced expression of IL-8 was mainly regulated by nuclear factor-kappa B (NF-kappa B). 1346619 induced the activation of NF-kappa B through I kappa B kinase (IKK) activation, I kappa B phosphorylation and NF-kappa B nuclear translocation. Furthermore, the inhibition of IL-8 or blockade of the IL-8 receptor attenuated the U46619-induced endothelial cell permeability by modulating the cell-cell junctions. Overall, these results suggest that U46619 promotes vascular permeability through the production of IL-8 via NF-kappa B activation in endothelial cells. (C) 2010 Elsevier Inc. All rights reserved.

키워드

Thromboxane A(2)Interleukin-8Endothelial cellsVascular permeabilityVASCULAR-PERMEABILITYGROWTH-FACTORGENE-EXPRESSIONCARDIOVASCULAR-DISEASEOXIDATIVE STRESSCELL MIGRATIONVE-CADHERINANGIOGENESISRECEPTORACTIVATION

식별자

WoS UID
000279974600008